Company Filing History:
Years Active: 2006
Title: Lynne Jean Lawrence: Innovator in Insulin Receptor Research
Introduction
Lynne Jean Lawrence is a prominent inventor based in Brunswick, Australia. She has made significant contributions to the field of biochemistry, particularly in the design of agonists and antagonists to the insulin-like growth factor (IGF) receptor. Her work has implications for understanding insulin receptor binding and its related molecular structures.
Latest Patents
Lynne holds a patent for a method of designing agonists and antagonists to the IGF receptor. This patent, which is titled "Method of designing agonists and antagonists to IGF receptor," discloses the identification of the human insulin receptor binding site sequence of certain spatial molecular structures conforming to such binding site. It also includes certain insulinomimetic sequences, which are crucial for advancing research in this area. She has 1 patent to her name.
Career Highlights
Lynne is affiliated with the Commonwealth Scientific and Industrial Research Organisation (CSIRO), where she has been instrumental in various research initiatives. Her work at CSIRO has allowed her to explore innovative solutions in the field of insulin receptor research.
Collaborations
Throughout her career, Lynne has collaborated with notable colleagues, including John David Bentley and Paul Alexander Tulloch, who have contributed to her research endeavors. Their combined expertise has enhanced the impact of her work in the scientific community.
Conclusion
Lynne Jean Lawrence is a trailblazer in the field of insulin receptor research, with a focus on designing effective agonists and antagonists. Her contributions continue to influence advancements in biochemistry and molecular biology.